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Objectives: Adoption and advances in endovascular surgery have
improved outcomes of vascular emergencies. We evaluated whether similar
trends apply to the treatment of acute mesenteric ischemia (AMI) using
a large inpatient database.
Methods: The Nationwide Inpatient Sample (2003-2010) was
queried using International Classiﬁcation of Diseases, Ninth Revision
code for AMI (557.1). Patients who had any open vascular or endovascular
procedures were selected. This cohort was divided into the open vascular
group (OVG) and endovascular group (EVG) based on the International
Classiﬁcation of Diseases, Ninth Revision procedure codes for primary
and secondary procedures. Bivariate analyses were performed using c2
test, t-test, and gamma regression when appropriate. Logistic regression
was used to determine factors affecting mortality while adjusting for con-
founding variables.
Results: We identiﬁed 6683 patients of which majority had an
endovascular procedure (4187, 62.7% vs 2496, 37.3%; P < .001) with
an overall in-hospital mortality rate (IHM) of 17.4%. Age, race, and
sex were similar across groups EVG had a signiﬁcantly higher Elixhauser
comorbidities index (3 6 1.6 vs 2.76 1.5; P ¼ .007) and a signiﬁcantly
higher rate of peripheral vascular disease than OVG (44.5% vs 29.2%;
P < .001). Despite this, EVG had signiﬁcantly lower in-hospitalmortality (IHM) rates (15.3% vs 21.2%, P ¼ .006), median charges
($72,907 vs $101,762; P < .001), and length of stay (9 vs 14 days;
P < .001) (Fig). Over the 8-year period of study, there was no change
in the overall mortality rate among EVG or OVG groups. Factors
affecting mortality rate included age (OR, 1.03; 95% CI, 1.02-1.04; P <
.001) and open surgery (OR, 1.45; CI, 1.07-1.96; P ¼ .016). Presence
of peripheral vascular disease correlated with decreased overall mortality
(OR, 0.60; CI, 0.43-0.85; P ¼ .004).
Conclusions: Despite incorporation of more advanced endovascular
therapies, the mortality rate for AMI remains unchanged throughout the
study period. Type of surgery and age are the most signiﬁcant factors
affecting mortality with EVG patients having better survival despite higher
morbidity indices.
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